GS vs WFC

The deterministic health profile is concerning, highlighted by a weak Piotroski F-Score of 2/9, indicating deteriorating fundamental strength. While the stock trades at a significant discount to its growth-based intrinsic value ($1513.06), it sits well above its defensive Graham Number ($641.39). Strong earnings growth (17.3% YoY) and consistent quarterly beats are currently offsetting severe bearish signals from insider selling and a low technical trend score. The overall outlook is a conflict between strong operational performance and weakening financial health metrics.

WFC presents a stark contrast between poor deterministic health and strong valuation/growth metrics. The Piotroski F-Score of 2/9 indicates weak financial health, which heavily penalizes the fundamental baseline. However, the stock is trading almost exactly at its Graham Number ($86.56), suggesting it is fairly valued defensively, while its intrinsic value ($166.83) suggests significant long-term upside. Steady earnings growth of 13.1% YoY and a sustainable payout ratio provide a buffer against the bearish insider sentiment and weak health scores.